澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TELIX PHARMACEUTICALS LTD

15.670

-1.090-6.50%

成交量：219.33萬

成交額：3,474.78萬

市值：53.08億

市盈率：117.82

高：16.610

開：16.450

低：15.500

收：16.760

52周最高：18.320

52周最低：8.260

股本：3.39億

流通股本：2.75億

量比：1.67

換手率：0.80%

股息：- -

股息率：- -

每股收益(TTM):0.133

每股收益(LYR):-0.029

淨資產收益率：7.36%

總資產收益率：2.71%

市淨率：7.81

市盈率(LYR):-532.63

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

Telix Pharmaceuticals預計2026財年營收及其他收入將突破10億美元

Telix Pharmaceuticals與摩根士丹利及威廉·布萊爾簽署股票分銷協議

Telix Pharmaceuticals持續推進：美國生物製品許可申請重新遞交進入關鍵階段

澳大利亞Telix製藥公司因季度營收表現強勁而股價上漲

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/TLX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":15.67,"timestamp":1789107120000,"preClose":16.76,"halted":0,"volume":2193327,"delay":0,"changeRate":-0.06503579952267312,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.1329977691020636,"marketStatus":"休市中","change":-1.09,"latestTime":"09-11 16:12:00 AEST","open":16.45,"high":16.61,"low":15.5,"amount":34747785,"amplitude":0.066229,"askPrice":16,"askSize":1500,"bidPrice":15.55,"bidSize":6425,"shortable":3,"etf":0,"ttmEps":0.1329977691020636,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789344000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":16.76,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":1.6678389730785266,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":16.76,"auctionPrice":15.67,"auctionVolume":394284,"auction":3,"marketStatus":"盘后竞价","timestamp":1789107003557}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.02942,"volumeRatio":1.6678389730785266,"shares":338721355,"dividePrice":0,"high":16.61,"amplitude":0.066229,"preClose":16.76,"low":15.5,"week52Low":8.26,"pbRate":"7.81","psRate":"4.27","week52High":18.32,"institutionHeld":0,"latestPrice":15.67,"committee":0.621451,"eps":0.1329977691020636,"divideRate":0,"volume":2193327,"delay":0,"ttmEps":0.1329977691020636,"open":16.45,"prevYearClose":11.2,"prevWeekClose":16.47,"prevMonthClose":15.36,"prevQuarterClose":16.58,"fiveDayClose":16.47,"twentyDayClose":16.73,"sixtyDayClose":14.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1117100091","title":"Telix Pharmaceuticals預計2026財年營收及其他收入將突破10億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117100091","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117100091?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:55","pubTimestamp":1787190931,"startTime":"0","endTime":"0","summary":"8月20日（路透社）——Telix Pharmaceuticals Limited宣布，其2026财年的营收及其他收入预计将超过10亿美元。该公司上半年集团营收达到4.77亿美元，税后利润为3800万美元。\n此外，Telix已与摩根士丹利和William Blair & Co签署了股权分销协议，旨在建立“按市价”融资机制。这一举措预计将为公司提供更多资本运作的灵活性。\n更多公司详情，请参考TLX.AX的相关报道。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136595917","title":"Telix Pharmaceuticals與摩根士丹利及威廉·布萊爾簽署股票分銷協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1136595917","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136595917?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 06:47","pubTimestamp":1787179647,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals已与摩根士丹利及威廉·布莱尔公司正式签署了一项股票分销协议。此举标志着该公司在资本市场上的又一重要战略布局，旨在进一步优化其融资渠道并增强财务灵活性。根据该协议，Telix Pharmaceuticals将通过这两家知名金融机构进行股票的分销活动。目前，Telix Pharmaceuticals尚未披露该协议的具体财务条款或预期的发行规模，但市场普遍预计，这一合作将为其带来可观的资本补充，助力其在全球范围内的创新药物研发和商业化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197836734","title":"Telix Pharmaceuticals持續推進：美國生物製品許可申請重新遞交進入關鍵階段","url":"https://stock-news.laohu8.com/highlight/detail?id=1197836734","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197836734?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 06:45","pubTimestamp":1787179508,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals在重新向美国递交Tlx250-Px（即Zircaix）生物制品许可申请的道路上，正不断取得实质性进展。\n公司表示，朝着近期重新提交这一关键申请的目标，已迈出坚实步伐。这一动向标志着Telix在推动其核心产品进入美国市场的进程中，又向前推进了一步。\n从目前披露的信息来看，Telix Pharmaceuticals显然正以积极的姿态，为Tlx250-Px及Zircaix在美上市铺平道路。市场对此持续关注，而公司的推进节奏也透露出对这款产品前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653226824","title":"澳大利亞Telix製藥公司因季度營收表現強勁而股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2653226824","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653226824?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 13:23","pubTimestamp":1784611422,"startTime":"0","endTime":"0","summary":"BUZZ-澳大利亚Telix制药公司因季度营收表现强劲而股价上涨更新：花旗、杰富瑞研报7月21日-** Telix Pharmaceuticals（TLX.AX）股价一度上涨4.2%至15.73澳元，创下自7月6日以来的最大盘中百分比涨幅** 这家大型生物制药公司 (link) 公布2026年第二季度营收为2.47亿美元，较去年同期增长21%** 预计2026财年营收及其他收入将超过10亿美元**","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N0A3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765646.SGD","LU2456880835.USD","LU0203347892.USD","BK4585","LU1668664300.SGD","TLX.AU","FTXO","LU1267930227.SGD","LU2236285917.USD","LU0170899867.USD","TFNS","LU1791807156.HKD","LU1201861249.SGD","LU0130102774.USD","BK4207","BK7067","LU0052756011.USD","LU0128525689.USD","LU2417539215.USD","LU2125154778.USD","BK4534","BK4566","LU0648001328.SGD","LU1162221912.USD","LU1244550577.SGD","LU1506573853.SGD","LU0098860793.USD","BK4504","LU2125154935.USD","LU1074936037.SGD","LU0314106906.USD","LU1244550494.USD","LU0310800965.SGD","IYF","LU0477156953.USD","IE00BSNM7G36.USD","LU1366192091.USD","LU0203345920.USD","LU1244550221.USD","BK4559","LU0162691827.USD","LU0980610538.SGD","LU2360032135.SGD","LU0130517989.USD","LU2462157665.USD","LU0106831901.USD","BK4588","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TLX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}